Critical Shoulder Angle and Acromial Index on 3D Models

Sponsor
Merve Sevgi INCE (Other)
Overall Status
Completed
CT.gov ID
NCT05742581
Collaborator
(none)
44
1
4
11.1

Study Details

Study Description

Brief Summary

Objective: The relationship between rotator cuff tears and morphological features of the shoulder joint has not been fully explained. The earlier studies are usually done with two-dimensional radiography images, but joint positions and bone formations could not be fully evaluated in two-dimensional images. This study aims to evaluate the relationship between rotator cuff tears and critical shoulder angle (CSA) and acromial index (AI) values in three dimensions.

Methods: This study examined computerized tomography of 24 rotator cuff tears (rotator cuff tear group) and 20 Bankart lesions, and no rotator cuff tears (control group). CSA and AI were measured on three-dimensional glenohumeral joint models obtained by three-dimensional reconstructions of computed tomography examinations.

The investigators anticipate results of this study will guide clinicians in revealing the etiology of rotator cuff degeneration and determining the surgical method to be used for treatment.

Condition or Disease Intervention/Treatment Phase
  • Other: Computed Tomography

Study Design

Study Type:
Observational
Actual Enrollment :
44 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Evaluation of the Relationship Between Critical Shoulder Angle and Acromial Index Measurements With Rotator Cuff Rupture on 3D Models
Actual Study Start Date :
Jun 1, 2019
Actual Primary Completion Date :
Aug 30, 2019
Actual Study Completion Date :
Sep 30, 2019

Arms and Interventions

Arm Intervention/Treatment
The rotator cuff tear group

Other: Computed Tomography
In our study, computerized tomography of 24 rotator cuff tears (rotator cuff tear group) and 20 Bankart lesions, and no rotator cuff tears (control group) were examined. CSA and AI were measured on three-dimensional glenohumeral joint models obtained by three-dimensional reconstructions of computed tomography examinations.

Control group

Other: Computed Tomography
In our study, computerized tomography of 24 rotator cuff tears (rotator cuff tear group) and 20 Bankart lesions, and no rotator cuff tears (control group) were examined. CSA and AI were measured on three-dimensional glenohumeral joint models obtained by three-dimensional reconstructions of computed tomography examinations.

Outcome Measures

Primary Outcome Measures

  1. Critical Shoulder Angle [2 hours]

    The critical shoulder angle is defined as the angle formed between the plane of the glenoid and the line connecting the most lateral border of the acromion process, as seen on the true anteroposterior radiograph of the shoulder.

  2. Acromial Index [2 hours]

    The acromial index is the distance between the glenoid plane and the lateral border of the acromion divided by the distance between the glenoid plane and the lateral aspect of the humeral head.

Eligibility Criteria

Criteria

Ages Eligible for Study:
17 Years to 80 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • A total of 44 patients, including 24 patients with proven rotator cuff tear by arthroscopic surgery (rotator cuff tear group) and 20 patients with proven Bankart lesion and no rotator cuff tear by arthroscopic surgery (control group), were included in the study.
Exclusion Criteria:
  • Those with an inflammatory disease and trauma history were not included in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Yuksek Ihtisas University Ankara Çankaya Turkey 06450

Sponsors and Collaborators

  • Merve Sevgi INCE

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Merve Sevgi INCE, Teaching Assistant, Lecturer, Yuksek Ihtisas University
ClinicalTrials.gov Identifier:
NCT05742581
Other Study ID Numbers:
  • 12022023
First Posted:
Feb 24, 2023
Last Update Posted:
Feb 24, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 24, 2023